A new report compiled by the Marijuana Policy Project demonstrates that legalizing recreational cannabis has not led to increased cannabis use among youth. In fact, data that was recently released shows decreases in youth cannabis use in 19 of the 21 states with before-and-after data.

“Over a decade into state-level cannabis legalization, the data is unequivocal: Legalization does not increase youth cannabis use. In fact, evidence suggests the opposite. By transitioning cannabis sales from the illicit market to a regulated system with age-restricted access, we’ve seen a decrease in youth cannabis use,” said Karen O’Keefe, director of state policies at the Marijuana Policy Project.

Nationwide, both the U.S. Centers for Disease Control and Prevention and the Monitoring the Future survey indicate significant drops in youth marijuana use between 2011 and 2023/2024, while half of the country legalized and regulated cannabis for adults. These findings challenge the notion that adult-use cannabis legalization is a gateway to increased youth use.
Continue reading

Newly released figures from the Maryland Cannabis Administration reveal that the state’s marijuana industry generated $1.14 billion in total sales in 2024.

December alone accounted for $98,867,338 in sales, with $74 million from recreational purchases and the remainder from medical marijuana. The average price per gram in December was $9.43.

Breaking down December’s sales, dried marijuana flower remained the top product, generating $46 million in revenue. Concentrates followed with $30 million, while edibles contributed $12.5 million to the monthly total.
Continue reading

December marijuana sales in Massachusetts topped $154 million.

Data released today by the Massachusetts Cannabis Control Commission (CCC) shows that there was $140.2 million worth of recreational marijuana sold in December. When combined with the $14.5 million in medical marijuana sold during the same month, there was $154.7 million in total marijuana sales.

December’s sales total brings the total for 2024 to $1.65 billion. The all-time total since 2018 is now $7.20 billion.
Continue reading

State Senators Lindsey Port, Matt Klein, and Clare Oumou Verbeten unveiled Senate File 204 today, a measure that would expand expungement and resentencing opportunities for past cannabis convictions.

If enacted, the legislation would amend Minnesota Statutes 2024, section 609A.06, subdivision 3, to broaden the scope of offenses eligible for expungement or resentencing. Under the bill, individuals convicted of first- through fifth-degree controlled substance crimes involving marijuana or tetrahydrocannabinols (THC) may qualify, provided specific criteria are met. These criteria include:

1. The absence of dangerous weapons, intentional bodily harm, or acts intended to cause fear of harm in connection with the offense.
2. The offense being classified as a lesser crime or no longer considered a crime following Minnesota’s marijuana reforms effective August 1, 2023.
3. Exhaustion of all appeals related to the conviction.

Continue reading

New research published in Molecular Psychiatry explores the anxiolytic effects of cannabidiol (CBD) on cue-induced anxiety, offering insights into its potential as a therapeutic treatment for anxiety disorders.

The study, conducted by researchers from the National Institutes of Health, Indiana University, and the Addiction Institute of Mount Sinai, examined how CBD influences behavior and molecular changes in the brain.

The researchers used a fear conditioning model in male rats, exposing them to a shock-paired odor to trigger cue-induced anxiety. CBD (10 mg/kg) was administered one hour before anxiety assessments. The results showed that CBD significantly reduced avoidance behavior, but only in rats exposed repeatedly to the anxiety-inducing cue.
Continue reading

U.S. Representative Dina Titus is advocating for cannabis banking reform, improved access to medical marijuana for veterans, and expanded research opportunities as top priorities for the 119th Congress.

These initiatives echo long-standing efforts that have yet to cross the legislative finish line, Titus acknowledged in an interview with MJBizDaily.

Titus, a Nevada Democrat and newly appointed co-chair of the Congressional Cannabis Caucus, has partnered with Minnesota Representative Ilhan Omar in this leadership role. Speaking with MJBizDaily shortly after Congress reconvened, she outlined her hopes for legislative action in a session dominated by new members and the return of Donald Trump to the presidency.
Continue reading

The U.S. Food and Drug Administration’s Center for Veterinary Medicine has released a request for information (RFI) soliciting comments from the public, particularly veterinarians, related to the use of cannabis-derived products (CDP) in animals.

The focus of this RFI is on cannabidiol (CBD) products and other products derived from hemp. The FDA is interested in general trends associated with these products, such as information about usage trends (e.g., product selection, indications, etc.), quality standards, benefits of use, potential drug interactions, adverse events and safety problems, and toxicological concerns.

Information received through this RFI “will enhance the FDA’s knowledge of potential safety signals associated with CDPs and improve the FDA’s understanding of veterinarians’ experiences related to the use of CDPs in their animal patients”, states the agency.
Continue reading

Ohio House Speaker Matt Huffman has softened his stance on altering the state’s marijuana legalization law, a significant change from his November promise to undo the law.

This change follows discussions with State Representatives Jamie Callender, a marijuana legalization advocate, and industry representatives.

Ohio voters approved Issue 2 in November 2023, legalizing marijuana for everyone 21 and older. The law allows individuals to grow up to six plants, with a maximum of 12 per household. Since the first licensed recreational marijuana store opened on August 7, the state has generated a combined $397,777,981 in marijuana sales.
Continue reading

An Idaho House committee voted Wednesday to advance legislation that would establish a mandatory minimum fine of $300 for possessing less than three ounces of marijuana.

The House Judiciary and Rules Committee approved the measure in a 10 to 4 vote after narrowly defeating a motion to hold it in committee.

Combat veterans and advocates with Kind Idaho, a group supporting medical marijuana legalization, spoke in opposition to the bill. Veterans testified that cannabis helps manage their severe health conditions without the risks associated with opioids. Criminal defense lawyers also voiced opposition, arguing mandatory minimums strip judges of discretion and fail to deter crime.
Continue reading

A public hearing for New Hampshire House Bill 53, which would allow qualifying patients and designated caregivers to cultivate cannabis for therapeutic use, is scheduled for January 22, 2025, at 10:15 a.m.

The hearing will take place in the Legislative Office Building, Room 201, under the Health, Human Services, and Elderly Affairs Committee. The measure was filed by State Representatives Wendy Thomas (D), Heath Howard (D), and Jim Kofalt (R).

If passed, the legislation would amend existing statutes to permit patients and caregivers to grow up to three mature cannabis plants, three immature plants, and 12 seedlings at a secured and enclosed cultivation location. Caregivers could cultivate on behalf of one patient and would not face criminal penalties provided they comply with reporting and security requirements. The bill also includes provisions for reporting cultivation sites to the state and sets limits on plant canopy size.
Continue reading